As seen from Figure 3B, the mean basal levels of Rad51 in cells derived from cancer patients with normal (1.5±0.4) and hypersensitive (1.4±0.1) reaction to RT was higher than that in cells derived from healthy donors (0.8±0.1). This evidence concerns the gene RAD51 and cancer.